GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Regen BioPharma Inc (OTCPK:RGBP) » Definitions » 5-Year Yield-on-Cost %

RGBP (Regen BioPharma) 5-Year Yield-on-Cost % : 0.00 (As of Dec. 11, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Regen BioPharma 5-Year Yield-on-Cost %?

Regen BioPharma's yield on cost for the quarter that ended in Sep. 2024 was 0.00.


The historical rank and industry rank for Regen BioPharma's 5-Year Yield-on-Cost % or its related term are showing as below:



RGBP's 5-Year Yield-on-Cost % is not ranked *
in the Biotechnology industry.
Industry Median: 1.56
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Regen BioPharma's 5-Year Yield-on-Cost %

For the Biotechnology subindustry, Regen BioPharma's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Regen BioPharma's 5-Year Yield-on-Cost % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Regen BioPharma's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Regen BioPharma's 5-Year Yield-on-Cost % falls into.



Regen BioPharma 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Regen BioPharma is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Regen BioPharma  (OTCPK:RGBP) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Regen BioPharma 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Regen BioPharma's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Regen BioPharma Business Description

Traded in Other Exchanges
Address
4700 Spring Street, Suite 304, La Mesa, CA, USA, 91942
Regen BioPharma Inc is a US-based biotechnology company. It focuses on the development of regenerative medical applications in the stem cell space. The company's principal products and services include HemaXellarate I, HemaXellerate II, dCell Vax, NR2F6, Tcellvax, identification of Small Molecules, and others. HemaXellarate I and HemaXellerate II is a cellular therapy designed to heal damaged bone marrow. dCell Vax is a therapy whereby dendritic cells of the cancer patient are harvested from the body. Tcellvax is an autologous cellular product comprised of NR2F6 gene-silenced peripheral blood mononuclear cells.